NCT06994728 Correlation of STN-DBS Induced Visuospatial Changes and Freezing of Gait
| NCT ID | NCT06994728 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of South Carolina |
| Condition | Parkinson Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 12 participants |
| Start Date | 2025-04-01 |
| Primary Completion | 2028-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 12 participants in total. It began in 2025-04-01 with a primary completion date of 2028-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research is to determine how deep brain stimulation (DBS) for Parkinson's disease affects attention and visuospatial function. Additionally, this study will evaluate how deficits in visual attention are associated with freezing of gait (FOG) in Parkinson's disease. There is currently no reliable treatment for FOG and little is understood about the underlying reason this occurs. Some recent research has found that stimulating the right side of the brain seems to improve FOG. The right side of the brain is also paramount for visual attention, which is why investigators are conducting this study.
Eligibility Criteria
Inclusion Criteria: * Subjects above 18 years of age * Subjects with freezing of gait * Subjects with bilateral STN-DBS surgery as part of their clinical care for Parkinson's disease Exclusion Criteria: * Uncorrected visual or hearing impairments, as indicated by self-report * Individuals who are pregnant or expect to become pregnant during the course of the study * Individuals with dementia or relevant brain lesions impacting cognition or gait
Contact & Investigator
Nathan DeTurk, MD
PRINCIPAL INVESTIGATOR
Medical University of South Carolina
Frequently Asked Questions
Who can join the NCT06994728 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Parkinson Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06994728 currently recruiting?
Yes, NCT06994728 is actively recruiting participants. Contact the research team at deturk@musc.edu for enrollment information.
Where is the NCT06994728 trial being conducted?
This trial is being conducted at Charleston, United States.
Who is sponsoring the NCT06994728 clinical trial?
NCT06994728 is sponsored by Medical University of South Carolina. The principal investigator is Nathan DeTurk, MD at Medical University of South Carolina. The trial plans to enroll 12 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.